Moneycontrol
HomeNewsBusinessEconomyCoronavirus pandemic| Will hoarding be the new normal in India?
Trending Topics

Coronavirus pandemic| Will hoarding be the new normal in India?

With a fear of running out of supplies, a trend of buying more than what is required of essential goods is being seen across India.

April 11, 2020 / 09:24 IST
Story continues below Advertisement
A woman wearing face mask walks past empty shelf of tissue papers at a supermarket in Hong Kong, Feb. 6, 2020.(AP Photo/Vincent Yu)

At a market in suburban Mumbai, an SUV drives in and the vehicle owner instructs the vegetable seller to pack 5 kilograms of every vegetable that is available. It is a big order and the seller is more than happy to do so.

When you ask the buyer if he is planning to donate these items or buying for someone else, pat comes the reply. "You never know what happens with this coronavirus (COVID-19) lockdown. At least I will have a good variety at home," he says.

Story continues below Advertisement

Vegetables are among perishable items and it is likely that the almost 50 kgs of produce he bought would start rotting within a few days. But he seemed to be least concerned.

As the murmurs of a lockdown extension has hit messaging platforms, the hoarding has already begun. Across India, customers starting queuing outside supermarkets and vegetable vendors from April 8, seemingly to pick up every product available.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show